Clinical Trials Directory

Trials / Completed

CompletedNCT06063096

Gastrointestinal Tolerance of D-allulose in Children

Gastrointestinal Tolerance of D-allulose in Children: an Acute, Randomised, Double-blind, Placebo-controlled, Cross-over Study

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
30 (actual)
Sponsor
Tate & Lyle · Industry
Sex
All
Age
6 Years – 8 Years
Healthy volunteers
Accepted

Summary

D-allulose, a low-calorie sugar, provides an attractive alternative to sucrose and added sugars in products. This study aimed to verify the tolerance of d-allulose in children, in doses that are Generally Recognised As Safe (GRAS) and below maximum tolerable levels on g/kg basis.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTD-alluloseFruit-flavoured drink with d-allulose at 2 dosages
DIETARY_SUPPLEMENTPlaceboFruit-flavoured drink with high fructose corn syrup

Timeline

Start date
2015-12-15
Primary completion
2016-03-03
Completion
2016-03-03
First posted
2023-10-02
Last updated
2023-10-02

Source: ClinicalTrials.gov record NCT06063096. Inclusion in this directory is not an endorsement.

Gastrointestinal Tolerance of D-allulose in Children (NCT06063096) · Clinical Trials Directory